| Bruderer, Roland M. (Biognosys 201601 Senior Scientist Mass Spectrometry) |
mass spectrometry (MS) |
Bruker (Group) |
Switzerland |
| Brudnick, Richard (Codiak BioSciences 201902 CBO + Head of Strategy before Bioverativ + Biogen + Bain & Co) |
Business Development Manager / Strategy Manager |
Codiak BioSciences Inc. |
United States (USA) |
| Bruellhoff, Kristina (PS Biotech GmbH 201305 Managing Director + Co-Founder) |
Managing Director |
PS Biotech GmbH |
Germany |
| Bruhn, Heiko (Mediatum 201209 Managing Director of Mediatum Schweiz GmbH) |
Managing Director |
Mediatum (Group) |
Switzerland |
| Bruinsma, Gosse B. (IDEA 201002– CEO before Axonyx 200606 CEO) |
Chief Executive Officer (CEO) |
IDEA AG |
Germany |
| Brummelkamp, Thijn (Haplogen 2010– Founder) |
Company Founder |
Haplogen Bioscience GmbH |
Austria |
| Brun, Virginie (PX'Therapeutics 201008– CSO + co-founder of Promise Advanced Proteomics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Aguettant (Group) |
France |
| Bruncko, Martin (EU (govt) 202201 Member of EIC Fund Investment Committee) |
Investment Manager |
EU (govt) |
EU (European Union) |
| Brunel, David (Biodesix 200810 CEO) |
Chief Executive Officer (CEO) |
Biodesix Inc. |
United States (USA) |
| Brunken, Heiko (Hochschule Bremen 201303 Professor for Ecology + Environmental Protection) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Brunner, Eduard M. (Creoptix 201909 Board Chairman) |
Board member, non-executive |
Spectris (Group) |
Switzerland |
| Brunner, H. |
n. a. |
Fraunhofer (Group) |
Germany |
| Brunner, Thomas (BioTek Instruments GmbH 200704 CEO) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Germany |
| Brunnhuber, Barbara (Mireca Medicines 202204 CEO) |
Chief Executive Officer (CEO) |
Mireca Medicines GmbH |
Germany |
| Bruno, Michael (Crosshair Therapeutics 202201 CEO + Founder) |
Chief Executive Officer (CEO) |
Crosshair Therapeutics Inc. |
United States (USA) |
| Bruno-Raimondi, Alfredo E. (Freibiotics 201012 Managing Director) |
Managing Director |
Freibiotics GmbH |
Germany |
| Bruns, Ingmar (Pieris 201710– VP Clinical Development before Bayer Pharmaceutical since 2013) |
Clinical Research Manager |
Pieris (Group) |
United States (USA) |
| Bruns, Olaf (Kompass Private Equity 200710– Managing Director before 3i Group before Arthur Andersen) |
Managing Director |
Kompass (Group) |
Germany |
| Bruns, Stefan (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
| Brunswiek, Soenke (PharmCell 201501 Director Business Development) |
Business Development Manager / Strategy Manager |
Lonza (Group) |
Netherlands |
| Brusdeilins, Martin (Tecan 201109–201409 RETIRED 9/14 before Ortho-Clinical Diagnostics + Roche Diagnostics) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Tecan (Group) |
Switzerland |
| Bruss, Marina (BioTek Instruments GmbH 200809) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Germany |
| Brutsche, Florian (UbiSim 202110 Co-Founder) |
Company Founder |
Labster (Group) |
Switzerland |
| Brübach, Amélie (Messe Stuttgart 201807 Head Communications Industry + Technology) |
public relations / investor relations |
Messe Stuttgart (Landesmesse Stuttgart GmbH) |
Germany |
| Brücher, Christoph |
n. a. |
Sanofi (Group) [since May 2011] |
Germany |
| Brück, Thomas (TU Munich 201604 Prof of Industrial Biocatalysis) |
Professor |
Technical University Munich (TU München, TUM) |
Germany |
| Brück, Wolfgang (Univ Göttingen 202302 Executive Board Member at Univ Medical Center formerly Charité) |
President/Director/Head of Research Organisation/Unit |
University of Göttingen (Georg August University) |
Germany |
| Brügemann, Lutz (Bruker 200905 Director RnD + Marketing) |
n. a. |
Bruker (Group) |
United States (USA) |
| Brüggemann, Andrea (Nanion Technologies GmbH 201102 Managing Director CSO) |
Managing Director |
Nanion (Group) |
Germany |
| Brüggen, Jochen |
n. a. |
PERSON |
|
| Brühlmann, Christian (Proteomedix 202001 COO/CFO) |
Chief Operating Officer (COO) |
Proteomedix AG |
Switzerland |
| Brümmer, Jens C. (Analytical Services North GmbH 2007) |
n. a. |
University of Hamburg |
Germany |
| Brüning, Kai (DEKA Investment 200601) |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Brünker, Hans-Günter (Direvo Industrial Biotech 200807– before amaxa 200501) |
n. a. |
Lonza (Group) |
Germany |
| Brüstle, Oliver (Univ Bonn 200809 Prof) |
Professor |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Brzózka, Krzysztof (Selvita 201511 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Selvita (Group) |
Poland |
| Brändle, Frank (Identxx GmbH 201104 Managing Director) |
Managing Director |
Identxx GmbH |
Germany |
| Brändle, Martin (Tecan 201201 Head Corporate Communications + Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Tecan (Group) |
Switzerland |
| Bräuchle, Christoph |
n. a. |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Bräuer, Philipp (EQT 202210 Associate at EQT Life Sciences) |
Associate (venture capital) |
EQT (Wallenberg family) (Group) |
Netherlands |
| Bräuer, Uwe (Genius Venture Capital GmbH 201309 investment manager of Technologiefonds MV) |
Investment Manager |
Genius Venture Capital GmbH |
Germany |
| Bröcker, Rudolf (BRAIN 201507 Head Finance & Controlling) |
Controller (management) |
BRAIN Biotech (Group) |
Germany |
| Brönnimann, Christian (Dectris 201708 CEO) |
Chief Executive Officer (CEO) |
Dectris Ltd. (CH) |
Switzerland |
| Brönstrup, Mark (Helmholtz 201503 Prof + Head of Chemical Biology at HZI) |
Professor |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Buchanan, Iain (Noxxon 201009– interim CEO before Novexel CEO before Vertex Pharmaceuticals) |
Chief Executive Officer (CEO) |
TME Pharma (Group) |
Germany |
| Buchberger, Bernd (MicroCoat Biotechnologie 201104 Managing Director) |
Managing Director |
MicroCoat Biotechnologie GmbH |
Germany |
| Buchbinder, Maurice (CryoTherapeutics 201607 CMO) |
Chief Medical Officer (CMO) |
CryoTherapeutics GmbH |
Germany |
| Buchenau, Udo |
n. a. |
Geneworx AG |
Germany |
| Bucher, Sascha Oliver (Forty51 Advisors 202204– Partner + Co-Founder) |
Partner (venture partner) |
Forty51 Ventures (Group) |
Switzerland |
| Buchholz, Bernd (Schleswig-Holstein (govt) 202001 Minister for Economic + Technology Affairs) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
| Buchholz, Mirko (PerioTrap Pharmaceuticals 201901– Managing Director) |
Managing Director |
PerioTrap Pharmaceuticals GmbH |
Germany |
| Buchholz, Stefan (Evonik 201203 Head Innovation Management at Advanced Intermediates Business Unit) |
n. a. |
Evonik (Group) |
Germany |
| Buchmayr, Daniela (Sarcura 202211 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sarcura GmbH |
Austria |
| Buckel, Peter (SuppreMol 2005–201304 CEO RETIRED 4/12 before atugen CEO + Xantos CEO + founder + Roche Mannheim) |
Chief Executive Officer (CEO) |
Baxter (Group) |
Germany |
| Buckland, Terry (Schauenburg 201308– Sales + Service Director at Markes Intl before Agilent + Varian + ABI) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Buckle, Isabelle (Institut Pasteur 201607 EVP Technology Transfer + Industrial Partnerships) |
IP Manager |
Institut Pasteur |
France |
| Buckman, Paul (Pathway Medical Technologies 201109 CEO) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Budd, David (Epistem 201603– CEO before Leica Biosystems + Siemens Healthcare Diagnostics + Bayer Diagnostics) |
Chief Executive Officer (CEO) |
Genedrive (Group) |
United Kingdom (GB) |
| Buddensiek, Dirk (Baden-Württemberg (govt) 201707 Managing Director of MBG Baden-Württemberg) |
Managing Director |
Baden-Württemberg (govt region) |
Germany |
| Buecheler, Uwe (Boehringer 201901 Head of Biopharmaceutical Business Unit) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Buechner, Ton (Akzo Nobel 201511 CEO + Novartis 201602– Board Director PROPOSED) |
Chief Executive Officer (CEO) |
Akzo Nobel (Group) |
Netherlands |
| Buehler, Kevin (Novartis 201203 Head of Alcon division) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Buesa, Carlos (Oryzon Genomics SA 201404 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Oryzon Genomics (Group) |
Spain (España) |
| Bufe, Albrecht (Protectimmun 200808 Founder) |
Company Founder |
Protectimmun GmbH |
Germany |
| Buhl, Thomas (Global Bioenergies 201606 Head of Business Development) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
| Buhlmann, Carsten (Eppendorf 201409 International Product Manager) |
Product Manager (personnel) |
Eppendorf (Group) |
Germany |
| Buhmann, Raymund (AptaIT GmbH 201707 Managing Director) |
Managing Director |
AptaIT GmbH |
Germany |
| Bui, Lynne A. (Khloris Biosciences 201904 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Khloris Biosciences Inc. |
United States (USA) |
| Builder, Stuart E. (Coherus 2010– Co-founder before at Genentech sind 1981) |
Company Founder |
Coherus BioSciences Inc. |
United States (USA) |
| Buis, Philipp (Coulter Partners 201703– Executive Director in Zurich before Jauch Assoc + Ward Howell/Neumann Intl) |
President/Director/Head Business Group/Unit/Division |
Coulter Partners (The Coulter Partnership Ltd.) |
Switzerland |
| Bujard, Hermann |
n. a. |
University of Heidelberg (Ruperto Carola) |
Germany |
| Bukowski, Nick (Schauenburg 201301 Business Development Manager at Almsco) |
Business Development Manager / Strategy Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Bulc, Ales (Global Bioenergies 201606 CEO of Global Bioenergies GmbH) |
Chief Executive Officer (CEO) |
Global Bioenergies (Group) |
Germany |
| Bulcke, Paul (Nestlé 201402 CEO) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
| Bulens, Frank (imec 202309 Partner at imec.xpand) |
Partner (venture partner) |
imec (Group) |
Belgium |
| Bull, David (Epigenomics 201703 Director of Marketing) |
Sales Manager / Marketing Manager |
Epigenomics (Group) |
United States (USA) |
| Bullard, Matthew (NovaQuest 202005) |
n. a. |
NovaQuest Capital Management |
United States (USA) |
| Buller, Fabian (Neurimmune 201804– CBO before JnJ Innovation + Covagen) |
Chief Business Officer (CBO) |
Neurimmune AG |
Switzerland |
| Buller, Ulrich (Fraunhofer 200811 Research Director) |
n. a. |
Fraunhofer (Group) |
Germany |
| Bullerdiek, Jörn |
n. a. |
University of Bremen |
Germany |
| Bullock, Heidi (Ingenuity 200603) |
n. a. |
Qiagen (Group) |
United States (USA) |
| Bulpin, Andrew (Millipore 200812 VP Upstream Bioprocess Business Unit) |
President/Director/Head Business Group/Unit/Division |
Merck (DE) (Group) |
United States (USA) |
| Bulthuis, Roel (Syncona 202304– Managing Partner before Inkef Capital + M Ventures + Merck Serono + Fortis Bank) |
Managing Partner (investment firm) |
Syncona (Group) |
United Kingdom (GB) |
| Bumol, Thomas F. (Lilly 201708 SVP Biotechnology + Immunology Research) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Bundis, Florian (Peqlab 200809) |
n. a. |
Avantor (Group) |
Germany |
| Bunge, Dörte (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Bunger, Maureen (Lonza 201703 Product Manager ADME-Tox Solutions) |
Product Manager (personnel) |
Lonza (Group) |
Switzerland |
| Bungers, Simon (Labfolder 201509 Managing Director + Founder) |
Managing Director |
Labforward (Group) |
Germany |
| Bunin, Barry (Collaborative Drug Discovery 202302 CEO + Founder) |
Chief Executive Officer (CEO) |
Collaborative Drug Discovery Inc. (CDD) |
United States (USA) |
| Buono, Stefano (Advanced Accelerator Applications 201402 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
France |
| Bur, Tilmann (ReLive 202301 Managing Director of Co.don GmbH) |
Chief Executive Officer (CEO) |
ReLive (Group) |
Germany |
| Burckhardt, Andreas (MC Services 201304– Executive Director Corporate Broking before WestLB) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Burckhardt, Peter E. (Basel Inkubator 201603 CEO) |
Chief Executive Officer (CEO) |
Basel Inkubator (University of Basel + FHNW) |
Switzerland |
| Burdack, Christoph (Priaxon AG 201401 CEO) |
Chief Executive Officer (CEO) |
Priaxon AG |
Germany |
| Burema, Peter (NextPharma 202101 CEO) |
Chief Executive Officer (CEO) |
NextPharma (Group) |
United Kingdom (GB) |
| Bures, Thomas (Tom) (Pieris 202110– promoted to CFO joined 2017 as VP FInance before Genocea Biosciences) |
Chief Financial Officer (CFO) |
Pieris (Group) |
United States (USA) |
| Burgaezy, Frank (Bruker 201201 President of Bruker AXS division) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Burgard, Luc (Sartorius 202111 Managing Director Sartorius Stedim FMT + Head of Operations Bioprocess Solutions Div) |
Managing Director |
Sartorius (Group) |
France |
| Burger, Anne (MedVenture Partners 2002– Director + Breath Therapeutics 201609– CFO + Curetis 201007–2012 CFO) |
Chief Executive Officer (CEO) |
MedVenture Partners GmbH |
Germany |
| Burger, Caroline (T-Curx 202209– Global Head Business Development before Nuvisan) |
Business Development Manager / Strategy Manager |
T-Curx GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 9 10 11 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
